Anbio Biotechnology, headquartered in Germany, is a leading player in the biotechnology industry, specialising in innovative solutions for agricultural and environmental applications. Founded in 2015, the company has rapidly established itself as a pioneer in the development of biostimulants and biofertilisers, aimed at enhancing crop yield and sustainability. With a strong presence in Europe and expanding operations in Asia, Anbio Biotechnology focuses on harnessing natural processes to improve soil health and plant resilience. Their core products, which include advanced microbial formulations, stand out for their efficacy and eco-friendliness, setting new standards in sustainable agriculture. Recognised for its commitment to research and development, Anbio has achieved significant milestones, positioning itself as a trusted partner for farmers and agronomists seeking to optimise productivity while minimising environmental impact.
How does Anbio Biotechnology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Anbio Biotechnology's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Anbio Biotechnology, headquartered in Germany (DE), currently does not report any carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established specific reduction targets or climate pledges at this time. Without emissions data or defined commitments, it is challenging to assess their climate impact or sustainability initiatives. As the industry increasingly prioritises carbon neutrality and climate action, Anbio Biotechnology may need to consider developing measurable targets and strategies to align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Anbio Biotechnology has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
